ONeil, PhD, director of the Weight Management Center and a professor of psychiatry and behavioral sciences at the Medical University of South Carolina
Ethics declarations Conflict of interest The authors hereby affirm that there are no conflicts of interest to disclose
Pre trial oral antidiabetes agents were continued as background therapy except for DPP 4 inhibitors or thiazolidinediones in both treatment arms
Surgeons fee, anesthesia (and who administers it), accredited facility fee, compression garments, all follow-up visits, and the policy on touch-ups
Sitagliptin protects renal glomerular endothelial cells against high glucose-induced dysfunction and injury
The 2023-2024 semaglutide shortage pushed many patients to tirzepatide